[ Price : $8.95]
The FDA Office of Regulatory and Emerging Science publishes a report describing agency efforts to research cybersecurity and advan...[ Price : $8.95]
FDA has approved Sanofi and Regenerons Dupixent (dupilumab) for treating adult patients with bullous pemphigoid that mainly affect...[ Price : $8.95]
FDA approves Incytes Monjuvi (tafasitamab-cxix) in combination with lenalidomide and rituximab for treating adults with relapsed o...[ Price : $8.95]
FDA clears a DeepEcho 510(k) for its artificial intelligence-based fetal ultrasound analysis platform.[ Price : $8.95]
FDA approves a Cycle Pharmaceuticals NDA for Harliku (nitisinone) tablets for reducing urine homogentisic acid in adult patients w...[ Price : $8.95]
Bavarian Nordic enters into an agreement to sell for $160 million a priority review voucher that was awarded for gaining approval ...[ Price : $8.95]
A Texas federal judge rules FDA acted properly in removing Novo Nordisks Ozempic and Wegovy from its drug shortage list.[ Price : $8.95]
Former FDA commissioner Scott Gottlieb expects FDA will reevaluate Sareptas approval of Duchenne muscular dystrophy gene therapy E...